Wegovy vs Mounjaro, Saxenda & UK Alternatives (2026)
A UK-focused comparison of weight-management medications: Wegovy (semaglutide) versus Mounjaro (tirzepatide), Saxenda (liraglutide), plus non-injectable options. Covers: how they work, what results to expect, side effects, NHS vs private access, switching considerations, and cost planning. If you also want a dedicated provider breakdown, you can compare current Mounjaro prices in the UK.
🧭 Quick Navigation
UK licensed options · Effectiveness & expectations · Side effects: prevention + rescue plan · NHS vs private access · Switching medications · Which option fits you? · FAQs✅ UK Licensed Weight-Management Options (Adults)
| Medication | Active ingredient | How it works (simple) | Dosing | Best for |
|---|---|---|---|---|
| Wegovy | Semaglutide (weight-management dose) | GLP-1 only (appetite + satiety + slower gastric emptying) | Weekly injection (titrated) | People wanting a strong weekly GLP-1 option with extensive safety/usage experience |
| Mounjaro | Tirzepatide | Dual GIP + GLP-1 (two appetite/metabolic signals) | Weekly injection (titrated) | People prioritising maximum average weight loss, when suitable and available |
| Saxenda | Liraglutide (weight-management dose) | GLP-1 only (older generation) | Daily injection (titrated) | People who prefer daily dosing or can’t use/access weekly injectables |
| Mysimba | Naltrexone + bupropion | Acts on appetite/craving pathways in the brain | Oral tablets (titrated) | Selected patients where injectables aren’t suitable |
| Orlistat | Orlistat | Reduces fat absorption in the gut | Oral capsules with meals | Budget-focused option or when other meds aren’t suitable |
Diabetes medicines sometimes discussed for weight loss (not the licensed obesity products)
| Medicine | Licensed indication | Notes |
|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes | Semaglutide at lower doses than Wegovy; off-label weight-loss use may be discussed but isn’t the standard route |
| Victoza (liraglutide) | Type 2 diabetes | Liraglutide at lower doses than Saxenda; not the standard weight-management product |
🔬 Effectiveness & What “Good Progress” Looks Like
A key UK point: NICE-style pathways for weight-management medicines are generally linked to structured services, lifestyle support, and stopping rules if you aren’t responding sufficiently. Private providers also monitor response and tolerability, but criteria and follow-up vary.
How to interpret results without getting misled
- Compare like-with-like: outcomes differ with baseline BMI, diabetes status, dose reached, and time on treatment.
- Look at the trend: weekly fluctuations happen. Focus on a 4–6 week rolling trend, not single weigh-ins.
- Plateaus happen: they’re not always medication failure; intake drift, low protein, and low activity are common causes.
🛡️ Side Effects: Prevention + “Rescue Plan” (Practical UK Guide)
For Wegovy, Mounjaro, and similar medicines, side effects are most often gastrointestinal, especially when starting or increasing dose. The goals: reduce severity, prevent dehydration/constipation, and know when to seek help.
| Problem | Prevention (best habits) | Rescue (when it’s happening) | Red flags (get help) |
|---|---|---|---|
| Nausea | Small meals; slower eating; reduce fatty/greasy foods; protein-first; avoid large late meals; keep dose day consistent | Ginger/peppermint; bland foods; cold foods; sip fluids little-and-often; ask a clinician about anti-nausea meds if persistent | Can’t keep fluids down; dizziness/fainting; persistent severe abdominal pain |
| Diarrhoea | Avoid very fatty meals + heavy alcohol near dose day; gradual fibre changes | Oral rehydration/electrolytes; simple foods (rice/bananas/toast); pharmacy advice on OTC options if appropriate | Lasting >24–48h with dehydration, blood in stool, severe weakness |
| Constipation | Regular fluids; daily walking; fibre build-up slowly; include fruit/veg; don’t “accidentally” under-drink | Soluble fibre (oats/psyllium); warm drink AM; consider short-term OTC options if needed | Severe pain, vomiting, no bowel movement + no gas, or symptoms worsening rapidly |
| Reflux/heartburn | Smaller dinner; avoid late meals; reduce spicy/greasy foods; don’t lie down after eating | Pharmacy antacids/alginate; speak to clinician if frequent | Chest pain, black stools, vomiting blood (emergency) |
| Fatigue | Don’t crash calories; prioritise protein; hydration; add light resistance training | Check intake; reduce overly aggressive deficit; discuss blood tests if persistent | Severe weakness, confusion, fainting |
- Don’t jump doses early. If symptoms are rough, ask about staying longer at the current dose.
- Protein-first + smaller meals beats “just eat less”.
- Hydration matters — headaches/dizziness/constipation are often dehydration + low intake.
- If vomiting/diarrhoea is heavy: treat dehydration first (electrolytes), then speak to a clinician.
🏥 NHS vs Private Access (UK Reality Check)
NHS (specialist weight-management services)
- Wegovy (semaglutide for weight management): access is typically through a structured NHS weight management service, with diet + activity support and pathway rules such as stopping criteria and defined review points.
- Mounjaro (tirzepatide for weight management): access and rollout depend on local pathways, commissioning, and service capacity, even where national guidance is supportive.
- Other options: availability can vary by local commissioning, service capacity, and local pathway design.
Private clinics/pharmacies
- Typically faster access, but you pay monthly and must meet provider criteria (often BMI thresholds + health history).
- Good providers require screening, explain risks, and provide follow-ups (especially around titration).
- Always check: consultation fees, delivery fees, refund/supply policies, and clinical support responsiveness.
🔄 Switching Between Medications (General Principles)
- Switching happens for cost, tolerance, supply, or inadequate response.
- Don’t switch at “full dose” without clinical guidance — many switches require re-titration or stepwise changes.
- Washout timing varies by medication and side effects. Your prescriber should provide a personalised plan.
🎯 Which Option Fits You Best?
Choose Wegovy (semaglutide) if:
- ✅ You want a strong, well-established weekly GLP-1 option
- ✅ You value predictable titration and broad real-world experience
- ✅ You’re exploring NHS specialist-service pathways where available
Consider Mounjaro (tirzepatide) if:
- ✅ You’re prioritising maximum average weight loss and it’s clinically appropriate
- ✅ Weekly dosing suits you
- ✅ You’re comfortable with careful titration and close monitoring
Consider Saxenda (liraglutide) if:
- ✅ You prefer daily dosing control
- ✅ Weekly injectables aren’t suitable or available
- ✅ You previously did well on liraglutide
Consider non-injectable options if:
- ✅ You can’t tolerate GLP-1 medicines, have contraindications, or strongly prefer tablets
- ✅ You want a lower-cost option (with more modest expected results)
💷 Live Wegovy Prices UK
Compare current prices across providers for your prescribed dose:Loading price comparison…
❓ FAQs
Is Mounjaro better than Wegovy?
Many people see greater average weight loss with tirzepatide, but “better” depends on tolerability, medical history, cost, availability, and what you can stick to long term. For many people, Wegovy is an excellent balance of effectiveness and experience. Your prescriber should match the option to your risk profile and goals.
Do side effects mean Wegovy isn’t for me?
Not necessarily. Side effects often peak when starting and during dose increases. Slower titration, smaller meals, hydration/electrolytes, and constipation prevention solve most issues. Seek clinical advice if symptoms are severe or persistent.
Can I switch if I plateau?
Yes, switching is possible under medical supervision. But plateaus are often intake drift + low protein/activity rather than “drug failure”. A prescriber may extend time at a dose, adjust your plan, or switch medication if response is inadequate.
Is Ozempic the same as Wegovy?
Same active ingredient (semaglutide) but different licensed indications and dose strengths. Wegovy is the weight-management product; Ozempic is the diabetes product.
How long do people stay on Wegovy?
Weight management is often long-term. Some people continue at a maintenance dose rather than stopping. Stopping can lead to appetite return and weight regain, so any exit plan should be clinician-led.